June 3, 2025 01:35 PM EDT

FDA commissioner tells Hawley he's 'committed' to doing a mifepristone review

Alexis Kramer

Deputy Editor

FDA chief Marty Makary told Sen. Josh Hawley (R-MO) this week that he’s “committed” to reviewing the abortion pill mifepristone, marking the clearest pledge to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA commissioner tells Hawley he's 'committed' to doing a mifepristone review

Alexis Kramer

Deputy Editor

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

A decade after its ill-fated $40.5B megadeal, Teva pivots from generics to innovation

Biotech ranks as China’s best shot to surpass US in emerging tech, report finds

Omada Health is going public on Friday at a $1.1B valuation

FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees

Trump's health appointees pledge support for cell and gene therapies at FDA roundtable

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...

FDA com­mis­sion­er tells Haw­ley he's 'com­mit­ted' to do­ing a mifepri­s­tone re­view

Deputy Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FDA commissioner tells Hawley he's 'committed' to doing a mifepristone review